Low Vision Research Centre of Milan, p.zza Sempione 3, Milan, Italy.
Division of Clinical Neurosciences, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom.
Restor Neurol Neurosci. 2020;38(3):223-237. doi: 10.3233/RNN-190970.
To assess whether treatment with the Limoli Retinal Restoration Technique (LRRT) can be performed in patients with retinitis pigmentosa (RP), grafting the autologous cells in a deep scleral pocket above the choroid of each eye to exert their beneficial effect on the residual retinal cells.
The patients were subjected to a complete ophthalmological examination, including best corrected visual acuity (BCVA), close-up visus measurements, spectral domain-optical coherence tomography (SD-OCT), microperimetry (MY), and electroretinography (ERG). Furthermore, the complete ophthalmological examination was carried out at baseline (T0) and at 6 months (T180) after surgery. The Shapiro-Wilk test was used to assess the normality of distribution of the investigated parameters. A mixed linear regression model was used to analyse the difference in all the studied parameters at T0 and T180, and to compare the mean change between the two groups. All statistical analyses were performed with STATA 14.0 (Collage Station, Texas, USA).
LRRT treatment was performed in 34 eyes of 25 RP patients recruited for the study. The eyes were classified in two groups on the basis of foveal thickness (FT) assessed by SD-OCT: 14 eyes in Group A (FT≤190μm) and the remaining 20 ones in Group B (FT > 190μm). Although it had not reached the statistical significance, Group B showed a better improvement in BCVA, residual close-up visus and sensitivity than Group A.
Previous studies have described the role of LRRT in slowing down retinal degenerative diseases. Consequently, this surgical procedure could improve the clinical and rehabilitative prognostic parameters in RP patients. On the other hand, further clinical research and studies with longer follow-up will be needed to evaluate its efficacy.
评估 Limoli 视网膜修复技术(LRRT)是否可用于治疗色素性视网膜炎(RP)患者,通过将自体细胞移植到每只眼睛脉络膜上方的深巩膜囊中,发挥对残余视网膜细胞的有益作用。
对患者进行全面的眼科检查,包括最佳矫正视力(BCVA)、近距离视力测量、光谱域光学相干断层扫描(SD-OCT)、微视野(MY)和视网膜电图(ERG)。此外,在手术前(T0)和术后 6 个月(T180)进行全面的眼科检查。采用 Shapiro-Wilk 检验评估研究参数的分布正态性。采用混合线性回归模型分析 T0 和 T180 时所有研究参数的差异,并比较两组之间的平均变化。所有统计分析均采用 STATA 14.0(美国德克萨斯州科勒尔盖布尔斯)进行。
研究共纳入 25 例 RP 患者的 34 只眼进行了 LRRT 治疗。根据 SD-OCT 评估的黄斑中心凹厚度(FT),将眼分为两组:A 组 14 只眼(FT≤190μm)和 B 组 20 只眼(FT>190μm)。尽管未达到统计学意义,但 B 组在 BCVA、残余近距离视力和敏感性方面的改善优于 A 组。
先前的研究描述了 LRRT 在减缓视网膜退行性疾病中的作用。因此,这种手术程序可以改善 RP 患者的临床和康复预后参数。另一方面,需要进一步的临床研究和更长时间的随访研究来评估其疗效。